Has Migvis Monduy received payments from drug or device companies?

Yes. Drug and device makers reported $454,856 in general payments to Migvis Monduy across 617 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Migvis Monduy did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Migvis Monduy come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Migvis Monduy

Neurology with Special Qualifications in Child Neurology · Miami, FLNPI 1184949182

Payments from drug & device makers

$454,856in general payments, 2019–2025

Across 617 payments — averaging $737.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Sarepta Therapeutics, Inc.$95K
CSL Behring$90K
Travere Therapeutics, Inc.$77K
Biogen$62K
Ipsen Biopharmaceuticals, Inc$40K
Catalyst Pharmaceuticals, Inc.$32K
plus $60K from 38 others

$4,244in research payments, 2019–2025

Across 12 payments — averaging $353.63 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Teva Pharmaceuticals USA, Inc.$4K

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Sarepta Therapeutics, Inc.	81	$95,014
CSL Behring	18	$89,940
Travere Therapeutics, Inc.	28	$76,772
Biogen	61	$61,527
Ipsen Biopharmaceuticals, Inc	19	$39,831
Catalyst Pharmaceuticals, Inc.	35	$32,028
PTC Therapeutics, Inc.	32	$23,577
Teva Pharmaceuticals USA, Inc.	28	$19,563
Novartis Gene Therapies, Inc. (fka Avexis, Inc.)	15	$8,290
UCB, Inc.	57	$1,739
ITF Therapeutics LLC	3	$1,640
Jazz Pharmaceuticals Inc.	44	$916
Neurelis, Inc.	44	$795
Sumitomo Pharma America, Inc.	15	$368
AbbVie(2 entities)	4	$361
NS Pharma, Inc.	12	$242
Ironshore Pharmaceuticals Inc.	16	$217
Greenwich Biosciences, Inc.	14	$192
Livanova USA, Inc.	8	$170
SK Life Science, Inc.	8	$153
Genentech USA, Inc.	8	$144
Corium, LLC	7	$139
Aquestive Therapeutics, Inc.	9	$135
Sunovion Pharmaceuticals Inc.	6	$118
Biocodex, Inc.	3	$100
Immedica Pharma US, Inc.	4	$89
Azurity Pharmaceuticals, Inc.	4	$89
Eisai Inc.	4	$82
AstraZeneca	3	$69
Aucta Pharmaceuticals, Inc.	3	$69
Biomarin Pharmaceutical Inc.	2	$68
Novartis	4	$64
Aprecia Pharmaceuticals, LLC	4	$61
Acadia Pharmaceuticals Inc	2	$49
Mallinckrodt Enterprises LLC	2	$39
Supernus Pharmaceuticals, Inc.	2	$38
Genentech, Inc.	1	$28
Amneal Pharmaceuticals LLC	1	$24
Merz Pharmaceuticals, LLC	1	$21
Neuropace, Inc.	1	$21
Upsher-smith Laboratories LLC	1	$20
Neurocrine Biosciences, Inc.	1	$19
Johnson & Johnson	1	$18
Saol Therapeutics Inc.	1	$17

How this compares

$454,856 in reported general payments places this provider in the 90th percentile of 137 neurology with special qualifications in child neurology providers in Florida.

See all neurology with special qualifications in child neurology providers in Florida →

Other neurology with special qualifications in child neurology in Miami

Ian MillerMiami$1.1M
Paula SchleiferMiami$394K
Anuj JayakarMiami$361K
Matt LallasMiami$339K
Trevor ResnickMiami$313K
Nelson SanchezMiami$255K
Elza VasconcellosMiami$245K
Marytery FajardoMiami$119K
Fernando GalanMiami$103K
Wilson Heredia NunezMiami$101K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →